Sonoma Pharmaceuticals, Inc. (SNOA)
Our coverage:

Sonoma Pharmaceuticals (SNOA) earnings: expect 48% revenue growth

Carla Olson | 5:14 pm ET, 09 Jun 2019

Sonoma Pharmaceuticals (SNOA) is announcing earnings on June 12. We combed through analyst estimates to understand what the company revenue and earnings are predicted to look like.

What should you expect from the upcoming earnings?

Revenue for the next quarter is expected to be $5M, which implies a 48% growth rate year-over-year.

Earnings per share are expected to come in at $-0.20. If this materializes, EPS will grow 78% year-over-year.

How did the stock do last month?

Over the last month, Sonoma Pharmaceuticals (SNOA) returned -4.45%.

For the latest price and information on Sonoma Pharmaceuticals, please visit Finstead and ask for "SNOA", "SNOA analysis" or "SNOA news".

Disclaimer: The news article above expresses the author’s opinion about the topic of the article. We strongly advise you not to base your investment decisions just on this article alone. If you’d like to become a writer for AskFinny Bites, please send us an email at hi@askfinny.com.


Sonoma Pharmaceuticals, Inc. (SNOA) Buy or Sell Stock Guide

Updated at: 2:39 pm ET, 12 Aug 2019

Are you looking for the analysis of Sonoma Pharmaceuticals, Inc. (SNOA) stock? Are you wondering what the bulls and the bears say about it?

If so, you came to the right place. In this stock guide, we will share with you 3 reasons to buy and 1 reasons to sell SNOA stock. You’ll get a perspective on what the bulls and the bears say about it.

The analysis below may be also helpful to you if you have any of the following questions about SNOA stock:

  • Is SNOA a buy or a sell?
  • Should I sell or hold SNOA stock today?
  • Is SNOA a good buy / investment?
  • What are SNOA analyst opinions, recommendations and ratings?

Let’s start with the bull case. Here are the reasons to buy SNOA stock:

1. SNOA Price/Sales ratio is 0.32, and it’s low compared to its industry peers’ P/S ratios. See SNOA forward Price/Sales ratio chart.

2. SNOA average analyst rating is Strong Buy. See SNOA analyst rating chart.

3. SNOA average analyst price target ($9.00) is above its current price ($5.61). See SNOA price target chart.

Now that you understand the bull case, let’s look at the reasons to sell SNOA stock (i.e., the bear case):

1. SNOA profitability is declining. The YoY profit margin change was -158.32percentage points. See SNOA profitability chart.

Now let's look at the key statistics for SNOA:

Metrics SNOA
Price $6.62
Average Price Target / Upside $9.00 / 35.95%
Average Analyst Rating Strong Buy
Industry Drug Manufacturers - Specialty & Generic
Sector Healthcare
Number of Employees 217
Market Cap $7.63M
Forward P/E Ratio -4.58
Price/Book Ratio 0.4
PEG N/A
Revenue (TTM) $19.31M
YoY Quarterly Revenue Growth 7.8%
Profit Margin -39.48%

What are your thoughts on SNOA?

If you liked this analysis, check out Buy or Sell Stock Guides for other stocks.

Disclaimer: The news article above expresses the author’s opinion about the topic of the article. We strongly advise you not to base your investment decisions just on this article alone. If you’d like to become a writer for AskFinny Bites, please send us an email at hi@askfinny.com.


Try AskFinny: the fastest way to get market data and insights on stocks, ETFs, mutual funds, and cryptocurrencies